2011 62 3 347-356.su c. g. wen x. bailey s. t. jiang w. rangwala s. m. keilbaugh s. a. flanigan a. murthy s. lazar m. a. wu g. d. a novel therapy for colitis utilizing ppar-gamma ligands to inhibit the epithelial inflammatory response.

gut 2006 55 9 1341-1349.celinski k. dworzanski t. korolczuk a. piasecki r. slomka m. madro a. fornal r. effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.

2005 28 5 802-807.guleria s. tiku a. k. koul a. gupta s. singh g. razdanv.

2009 15 3 341-352.dieleman l. a. palmen m. j. akol h. bloemena e. pena a. s. meuwissen s. g. van rees e. p. chronic experimental colitis induced by dextran sulphate sodium dss is characterized by th1 and th2 cytokines.

2004 136 1 30-39.ruyssers n. e. de winter b. y. de man j. g. loukas a. pearson m. s. weinstock j. v. van den bossche r. m. martinet w. pelckmans p. a. moreels t. g. therapeutic potential of helminth soluble proteins in tnbs-induced colitis in mice.

2010 48 4 496-501.boeck p. leal p. c. yunes r. a. filho v. c. lopez s. sortino m. escalante a. furlan r. l. zacchino s. antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones.

2016 41 11-18.santos f. a. silva r. m. campos a. r. de araujo r. p. lima r. c. jr. rao v. s. 18-cineole eucalyptol a monoterpene oxide attenuates the colonic damage in rats on acute tnbs-colitis.

2007 292 2 g657-g666.dworzanski t. celinski k. korolczuk a. slomka m. radej s. czechowska g. madro a. cichoz-lach h. influence of the peroxisome proliferator-activated receptor gamma ppar-gamma agonist rosiglitazone and antagonist biphenol-a-diglicydyl ether badge on the course of inflammation in the experimental model of colitis in rats.

cell 2014 156 6 1193-1206.bauer c. duewell p. mayer c. lehr h. a. fitzgerald k. a. dauer m. tschopp j. endres s. latz e. schnurr m. colitis induced in mice with dextran sulfate sodium dss is mediated by the nlrp3 inflammasome.

2005 15 3 407-410.gerova v. a. stoynov s. g. katsarov d. s. svinarov d. a. increased intestinal permeability in inflammatory bowel diseases assessed by iohexol test.

2006 22 2 85-89.kucharzik t. walsh s. v. chen j. parkos c. a. nusrat a. neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.

2001 159 6 2001-2009.bashashati m. habibi h. r. keshavarzian a. schmulson m. sharkey k. a. intestinal microbiota a regulator of intestinal inflammation and cardiac ischemia curr.

drug targets 2015 16 3 199-208.hakansson a. tormo-badia n. baridi a. xu j. molin g. hagslatt m. l. karlsson c. jeppsson b. cilio c. m. ahrne s. immunological alteration and changes of gut microbiota after dextran sulfate sodium dss administration in mice.

however these histopatho-logical changes were improved following treatment with zbeo doses of 20 40 and 80 mgkg a. only zbeo 80 mgkg had not generated a histopathological change in the colons of mice.

the inflammatory cytokine levels were significantly inhibited by the zbeo treatments a. we measured the mrna levels of tnf-a il-1b and il-12 in colonic tissue as well.

